Dasatinib in Advanced Squamous Cell Lung Cancer
This study has been terminated.
(Safety issues/concerns per DF/HCC PI)
Sponsor:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Bruce Johnson, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01491633
First received: October 5, 2011
Last updated: March 4, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | September 2013 |
| Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |